Mon, Dec 29, 2014, 3:26 AM EST - U.S. Markets open in 6 hrs 4 mins


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

simp08801 232 posts  |  Last Activity: 8 hours ago Member since: Apr 10, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • simp08801 by simp08801 Oct 12, 2014 11:03 AM Flag

    search this new story:

    "CDC: Protocol breach in treating Ebola patient"

    now CDC head is saying there was a protocal breach in treating first ebola patient and that all involved may now be at risk

    and remember, this dallas situation was supposed to be our ebola ground zero test case

  • Reply to

    2nd ebola case: the spooky part

    by simp08801 Oct 12, 2014 9:16 AM
    simp08801 simp08801 Oct 12, 2014 10:15 AM Flag

    no, I have zero hope for ANY srpt benefit of any kind via ebola

    it could possibly be used in that private, likely poorly controlled "trial" allegedly to occur in West Africa via that under $5 mil funded consortium

    absent that



    I believe the facts and circumstances of our government's focus make assuming otherwise foolish

  • Reply to

    2nd ebola case: the spooky part

    by simp08801 Oct 12, 2014 9:16 AM
    simp08801 simp08801 Oct 12, 2014 9:19 AM Flag

    and one more thing

    how many people has the 2nd ebola victim been in close contact with prior to developing the fever?

    she was not in quaratine

  • let me first say that I no longer believe there is ANY ebola opportunity for srpt, not just no money, but not even a platform validation event which would flow from srpt ebola drug supply being used on even a single patient ... its seems VERY clear that the US Gov passed on the srpt drug

    but having said that, this 2nd ebola case in Texas better wake our gov up from its coma

    this infected person was NOT the first patient's girlfriend who he had sex with, one of those kids he hugged and kissed, or any of his friends he came in contact with, all during his first 7 days in US

    the 2nd infected person is a US healthcare worker who was in a fully quaranteed area with all appropriate protocals in place (including full protective gear)

    not in West Africa, in some tent, but in a US hospital facility that was being treated like "US ebola ground zero"

    and she still got ebola

    our government has probably spent over $100,000,000 in the last month dropping bombs on ISIS, and the impact is that ISIS is about to take Bagdad (in other words, no impact)

    our government needs to decide immediately what companies its wants to support for ebola and it needs to start supporting them immediately

    and again, I do not believe srpt will be one of them

  • Reply to

    Has anyone looked at the posters on RNA's website.

    by whogo70 Oct 11, 2014 12:22 PM
    simp08801 simp08801 Oct 11, 2014 1:19 PM Flag

    now you understand WHY rna issued yesterday's press release


  • Reply to

    4th Biopsy Question

    by greyzone513 Oct 11, 2014 10:40 AM
    simp08801 simp08801 Oct 11, 2014 10:52 AM Flag


    this is a complex, widely misunderstood legal issue

    in actuality, the "disclose material info within 4 days thing is a myth

    public companies are legally required to re-up their material events disclosures quarterly in their 10Qs, and annually in their 10ks

    if you choose to disclose material info other than at these times, you must follow Reg FD and do such disclosures through 8ks

    there are certain enumerated events that should be disclosed via 8ks and not wait for next 10Q, but I do not think 4th biop is actually one of them, or at least the lawyers can dance on that issue

    yes, the 4th biop is megla material, but if the company thinks it can satisfy reg FD and keep it sealed until the next 10Q, there are lawyers who will say it can do that

    again, this legal disclosure issue is widely misunderstood

    and aside from the law side of it, most public companies want to disclose material events right away anyway

    and that has been assumed by most that they they have to

    they don't, other than enumerated items in the 8k list

    turning from legality to reality, any cg decision to hide that 4th biop info is pure lunacy

    its gunna leak, for all obvious reasons

    then he will have a reg FD problem and have to issue an 8k anyway

  • Reply to

    A few early tweets on the data fwiw

    by zwerp2000 Oct 11, 2014 9:07 AM
    simp08801 simp08801 Oct 11, 2014 10:31 AM Flag


    we have to remember that ppmd did in fact try to make an "investment" in srpt with the $400k "grant" that was actually an equity investment

    that grant never materialized, presumably at the hand of the CEO

    the grant was also at least double the investment ppmd offered rna at that time

    I do not know the details of these offers, so I cannot judge them

    but we must admit that ppmd did try to put money in srpt

  • quite informative piney posts on IV board, including backup links

    I really appreciate her research prowess, independent of my luv for her

  • Reply to

    WMS leak?

    by alleg180 Oct 10, 2014 3:18 PM
    simp08801 simp08801 Oct 10, 2014 3:53 PM Flag


    I own a ton of the stock

    I have lost confidence in the management to understand the market it functions in

    this view is through the eyes of a stock monkey, not a scientist

    divide the stock price by 6

    think what was public last time it was that price

    compare to what is now public

    its not just risk in the science

    the CEO has not had his A, B, or even C, game for months and months, in my view

    his worst move is not widely focused on

    he precisely and expressly set forth repeatedly, a detailed schedule which highlighted every data point blackout period

    and he attracted every quant short in the galaxy to fill in those voids

    dumb, dumb and dumber

    that is what is really behind the trading

    its not leaks of impending bad news

    its was actually his volunteering of a price schedule full of disclosure void black holes

    there is an entire universe of quant shorts who trade the holes, not the widget

    and worse yet, he constantly signals he is struggling to even meet the data points he guides to

    which makes the blackout periods essentially zero risk

    again, its not leaked bad news

    its screamed out news blackout periods

  • Reply to

    WMS leak?

    by alleg180 Oct 10, 2014 3:18 PM
    simp08801 simp08801 Oct 10, 2014 3:23 PM Flag

    I highly doubt the news is bad

    but the CEO did not understand that his failure to put the data out this week would engender fear about full data set

    the data will be released tomorrow

    IMO, it should have been out no later than today

    in the big picture it completely irrelevant, in comparison to 4th biop data

    IMO, the 4th biop data is bigger than the NDA filing, as that filing will likely be made before the 4th biop data is known


  • to claim the "2014 PATHETIC IMBECILES" award

    that RNA pr this am was a complete pathetic joke

  • 9/30 net short now at 12.5 mil shares

    up 700,000 shares in last two weeks of september

  • Reply to

    ebola trials started

    by simp08801 Oct 9, 2014 2:27 PM
    simp08801 simp08801 Oct 9, 2014 3:54 PM Flag

    the news folks call EVERYTHING a vaccine

  • "First Ebola vaccine trial in West Africa started, NBC News reports

    Researchers said the first trial of an Ebola vaccine in Africa has begun, according to NBC News, which noted that the vaccine being used was developed at the U.S. National Institute of Allergy and Infectious Diseases. NBC News also noted Ebola vaccine trials are being conducted at the National Institutes of Health in Washington, D.C. and in Britain. The report does not mention any company by name, but companies known to be working on Ebola vaccines or treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), NewLink Genetics (NLNK) and Chimerix (CMRX). "


  • simp08801 by simp08801 Oct 9, 2014 8:11 AM Flag

    I have extrapolated your srpt guidance and actual srpt trading data into a 40-Double D, 4k HD alogrithmic graph

    the results are uncanny

    I will be releasing said results at a future WMS (World Mamory Society) event, yet to be identified

  • Reply to

    And now ... the dump

    by nekkidshort Oct 6, 2014 7:02 PM
    simp08801 simp08801 Oct 7, 2014 8:33 AM Flag


    are you aware that the word "rump" rhymes so well with the words "pump" and "dump"?

    we need to figure out the meaning in this

  • "Ebola patient in Dallas struggling to survive, says CDC head"

    see CDC head quotes on tkmr

  • read this quote from new article:

    "The man in Dallas, who is fighting for his life, is the only patient to develop Ebola in the United States," Dr. Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention (CDC), said on CNN's "State of the Union."

    In a media briefing with reporters on Sunday, Frieden said he was scheduled to brief President Barack Obama on Monday.

    Frieden said doses of the experimental medicine ZMapp were "all gone" and that the drug, produced by San Diego-based Mapp Biopharmaceutical, is "not going to be available anytime soon."

    Asked about a second experimental drug, made by Canada's Tekmira Pharmaceuticals Corp, he said it "can be quite difficult for patients to take."


  • simp08801 by simp08801 Oct 5, 2014 4:18 PM Flag

    why was the texas ebola patient not given any experimental ebola drug

    I understand he may be too sick to justify it now, but he wasn't that sick 4 days ago

    that seems ridiculous to me

  • Reply to

    here is the day I long for ...

    by simp08801 Oct 4, 2014 12:47 PM
    simp08801 simp08801 Oct 4, 2014 4:22 PM Flag

    dear tred

    now do not be upset

    I have asked about this several times

    no responses to date match yours

    it was a little white lie

13.92+0.04(+0.29%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.